## 



## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 





## 

## 

## 

## 



## 

## 

## 

||||||Unrestricted|||
|---|---|---|---|---|---|---|---|
|||||Notes|Fundsf|2021<br>6|2020<br>6|
|Income and|Endowments|from:||||||
|Donations<br>and legacies|||||||11,735|
|Other trading|activities||||12,895|12,895|7,360|
|Total income|||||12,895|12,895|19,095|
|Expenditure||||||||
|Expenditure|on charitable|activities|||8,674|8,674|21,798|
|Total expenditure|||||8,674|8,674|21,798|
|Net Income/(expenditure)||and net movement|in funds for the|||||
|year|||||4,221|4,221|(2,703)|
|Reconciliation<br>offunds||||||||
|Total funds,|brought<br>forward||||93,922|93,922|96,625|
|Total funds,|carried forward|||13|98,143|98,143|93,922|



## 



## 

## 




## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

|DONATI|ONS||AND LEGACIES|||||||
|---|---|---|---|---|---|---|---|---|---|
||||||||Unrestricted|||
||||||||Funds|2021|2020|
||||||||6|6|6|
|Donation|from||BEAVRS Trading|Ltd|||||11,735|
|2020|||||||11,735||11,735|
|INCOME|FROM OTHER TRADING ACTIVITIES|||||||||
||||||||Unrestricted|||
||||||||Fundsf|2021f|2020f|
|Membership||subscriptions|||||12,895|12,895|7,360|
||||||||12,895|12,895|7,360|
|2020|||||||7,360||7,360|
|ANALYS|IS OF EXPENDITURE|||||||||
||||||Research|&|Retinal|||
||||||education||Outcomes|||
||||||projects||Project|2021|2020|
|||||||6|6|6|6|
|Direct project|||costs||||4,194|4,194|15,274|
|Support|costs||(note 5)||||2,171|2,171|3,353|
|Governance||costs (note 5)|||||2,309|2,309|3,171|
||||||||8,674|8,674|21,798|
|2020|||||16,524||5,274||21,798|



## 



## 

## 

## 

|llocated to ac|tivities at different percent|ages,<br>based on direct projec|t costs attributable|to each ac|tivity.|
|---|---|---|---|---|---|
|||General|Governance|||
|||support<br>f|costs<br>f|2021<br>f|2020<br>6|
|Management|costs|1,504||1,504|2,369|
|Computer costs||28||28|13|
|Bank charges||578||578|401|
|Other support|costs|61||61|570|
|Accountancy|fees||2,309|2,309|3,171|
|||2,171|2,309|4,480|6,524|
|2020||3,353|3,171||6,524|



## 

|2021|2020|
|---|---|
|F|E|
|2,309|3,171|



## 



## 

## 

## 

## 

## 

|||||2021|2020|
|---|---|---|---|---|---|
|||||E|E|
|Shares<br>in group undertakings|and participating|interests||||
|Shares<br>in group undertakings|and participating||interests:|||
|||||Subsidiary||
|||||Undertakings|Total|
|Cost|||||E|
|At 1 October 2020|||||1|
|At 30 September 2021||||||
|Net book value||||||
|At 30 September 2021||||||
|At 30 September 2020||||||



||||Country of|Country of|||Proportion|ofvoting|ofvoting|Principal||
|---|---|---|---|---|---|---|---|---|---|---|---|
|Undertaking|||incorporation||Holding||rights and|shares|held|activity||
||||||||2021|2020||||
|Subsidiary|undertakings|||||||||||
|BEAVRS Trading||Ltd|United|Kingdom|Ordinary|shares|100%|100%||Provision|of|
|||||||||||seminars|and|
|||||||||||exhibitions|for|
|||||||||||Vitreoretinal||
|||||||||||Surgeons||



|The summary<br>f|inancial<br>performance<br>ofthe subsidiary|is:||
|---|---|---|---|
|||2021|2020|
|||6|6|
|Turnover||15,718|91,865|
|Cost ofsales||(3,620)|(51,967)|
|Administrative|expenses|(25,692)|(24,530)|
|Net profit/(loss)||(13,594|15,368|
|Current assets||58,085|50,339|
|Current<br>liabilities||(59,943)|(38,603)|
|Net assets||1,858|11,736|
|Total equity||(1,858|11,736|





## 

## 

## 

||2021f|2020<br>6|
|---|---|---|
|Trade debtors|6,145|3,155|
|Due from group undertakings|2,130|2,300|
|Accrued income||11,735|
|Other debtors|58,577|58,577|
||66,852|75,767|
|CASH AND CASH EQUIVALENTS|||
||2021|2020|
||6|6|
|Cash at bank|65,906|62,439|



## 

|CREDITORS: amounts<br>falling due within one year|||
|---|---|---|
||2021|2020|
||F|F|
|Trade creditors|1,657|3,201|
|Accruals|22,134|32,499|
|Deferred income (note 12)|4,960|2,720|
|Other creditors|5,865|5,865|
||34,616|44,285|



|||||2021|2020|
|---|---|---|---|---|---|
|||||6|6|
|Balance|as at 1stOctober|||2,720|3,895|
|Amounts|released|from previous|periods|(2,720)|(3,895)|
|Resources deferred||in the period||4,960|2,720|
|Balance|as at 30th|September||4,960|2,720|





## 

## 

## 

## 

|||||Balance at||||Balance at|
|---|---|---|---|---|---|---|---|---|
|||||01.10.2020|Income|Expenditure|Transfers|30.09.2021|
|||||6|8|8|6|8|
|Unrestricted||Funds:|||||||
|General funds||||93,922|12,895|8,674||98,143|
|Total funds||||93,922|12,895|8,674||98,143|
|Movement|in|funds —previous||year:|||||
|||||Balance at||||Balance at|
|||||01.10.2019<br>f|Income<br>6|Expenditure<br>6|Transfers<br>8|30.09.2020<br>6|
|Restricted|Funds:||||||||
|Retinal Outcomes|||Project|2,427||5,274|2,847||
|Unrestricted||Funds:|||||||
|General funds||||94,198|19,095|16,524|(2,847)|93,922|
|Total funds||||96,625|19,095|21,798||93,922|



## 

## 

## 

|ANALY|SIS OF NET ASSETS B|ETWEEN FUNDS|||||
|---|---|---|---|---|---|---|
|||||Unrestricted|Restricted|Total|
|||||6|8|8|
|Fixed assets/investments||||1||1|
|Current|assets|||132,758||132,758|
|Current|liabilities|||(34,616)||(34,616)|
|Total net assets||||98,143||98,143|
|Analysis|of net assets between|funds —previous|year:||||
|||||Unrestricted|Restricted|Total|
|||||6|F|6|
|Fixed assets/investments||||1||1|
|Current|assets|||138,206||138,206|
|Current|liabilities|||(44,285)||(44,285)|
|Total net assets||||93,922||93,922|





## 

## 

##